Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Role of CBD Oil in Malignancy Management

Evidence-Based Indications for CBD Oil in Cancer

  • The American Society of Clinical Oncology recommends CBD combined with THC (1:1 ratio) as a third or fourth-line option for refractory nausea and vomiting in patients receiving moderately or highly emetogenic chemotherapy who have failed guideline-concordant antiemetic prophylaxis, with a weak strength of evidence and low quality evidence for THC:CBD extracts 1, 3

Cautions and Contraindications

  • The American Society of Clinical Oncology advises to use CBD with extreme caution in patients receiving immunotherapy due to potential interference with treatment efficacy, as cannabis consumption has been associated with reduced response rates to nivolumab, significant decrease in time to tumor progression, and decreased overall survival in patients with metastatic cancers 1, 2, 5
  • THC directly reduces the therapeutic effect of PD-1 blockade through suppression of T-cell antitumor immunity 5

Adverse Effects

  • Common adverse effects of CBD oil include euphoria, drowsiness, dizziness, vertigo, and hallucinations, with patients reporting sedation (19%), dizziness (10%), and disorientation (3%) in clinical trials 6

Quality of Life and Other Outcomes

  • The American Society of Clinical Oncology found no significant improvement in quality of life with CBD oil, as demonstrated in multiple studies, including a 2022 systematic review of six RCTs and a recent RCT of CBD oil versus placebo 6

Anticancer Effects

  • The American Society of Clinical Oncology states that there is a lack of evidence-based data supporting CBD oil as an anticancer treatment, and clinicians should advise patients that using cannabis/cannabinoids as cancer-directed treatment may cause significant clinical and financial toxicities without good-quality evidence of clinical benefit 1, 2, 3, 7

Clinical Approach

  • The American Society of Clinical Oncology recommends that clinicians explore goals and provide education about limited evidence when patients are using or considering CBD oil, and seek to minimize harm through proper dosing and monitoring 7, 8